Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06091995 · ClinicalTrials.gov registry record
Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients with Delayed Graft Function
A clinical trial of Use of Belatacept in Kidney Transplant Patients, sponsored by Methodist Health System.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06091995 is a study of Use of Belatacept in Kidney Transplant Patients that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06091995, a study of Use of Belatacept in Kidney Transplant Patients, is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the impact of one dose of belatacept in patients with Delayed Graft Function(DGF) on their time to renal recovery and corresponding rates of patient and graft survival, rejection, and incidence of BK virus(BKV), Epstein-Barr Virus(EBV) and/or cytomegalovirus (CMV) infections.
Conditions Studied
Interventions
- BEHAVIORAL impact of administering one dose of belatacept on Estimated Glomerular Filtration Rate(eGFR)
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-08-22 |
| Est. Completion | 2025-08-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06091995
The ClinicalTrials.gov registry entry for NCT06091995 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Use of Belatacept in Kidney Transplant Patients appearing as the primary indexed condition, and to 1 intervention - of which impact of administering one dose of belatacept on Estimated Glomerular Filtration Rate(eGFR) is the first listed.
NCT06091995 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06091995 about?
NCT06091995 is a clinical study titled "Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients with Delayed Graft Function". Evaluate the impact of one dose of belatacept in patients with Delayed Graft Function(DGF) on their time to renal recovery and corresponding rates of patient and graft survival, rejection, and incidence of BK virus(BKV), Epstein-Barr Virus(EBV) and/or cytomegalovirus (CMV) infections.
What is the current status of trial NCT06091995?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2022-08-22. Estimated completion is 2025-08-22.
What conditions does trial NCT06091995 study?
This clinical trial studies the following conditions: Use of Belatacept in Kidney Transplant Patients.
What interventions are being tested in trial NCT06091995?
The interventions under investigation include: impact of administering one dose of belatacept on Estimated Glomerular Filtration Rate(eGFR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06091995?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06091995 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.